Premium Nahrungsergänzungsmittel | artgerecht

Immunoglobulin Therapy – Effects, Uses & Side Effects

Immunoglobulin therapy is a medical treatment using antibodies derived from human blood plasma to strengthen or regulate the immune system.

Regular tips about health Regular tips about health

Things worth knowing about "Immunoglobulin Therapy"

Immunoglobulin therapy is a medical treatment using antibodies derived from human blood plasma to strengthen or regulate the immune system.

What is Immunoglobulin Therapy?

Immunoglobulin therapy involves the medical administration of immunoglobulins (antibodies) derived from the blood plasma of thousands of donors. It is used to support the immune system of patients who cannot produce sufficient antibodies on their own, or to modulate the immune response in certain autoimmune conditions. Immunoglobulins are proteins that play a central role in defending the body against pathogens.

Indications

Immunoglobulin therapy is used across a variety of medical conditions:

Primary immunodeficiencies: Congenital disorders in which the immune system produces little or no antibodies (e.g., agammaglobulinemia, common variable immunodeficiency).
Secondary immunodeficiencies: Acquired antibody deficiency states, for example due to blood cancers (multiple myeloma, chronic lymphocytic leukemia) or chemotherapy.
Autoimmune diseases: Conditions such as Guillain-Barre syndrome, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIDP), and immune thrombocytopenic purpura (ITP).
Inflammatory conditions: For example, Kawasaki disease in children.
Infection prophylaxis: Protection of immunocompromised individuals from certain infectious diseases.

Mechanism of Action

Immunoglobulins act in several ways within the body:

Substitution: Missing antibodies are replaced by the administered immunoglobulins, allowing the immune system to recognize and fight pathogens again.
Immunomodulation: In autoimmune diseases, high-dose intravenous immunoglobulins (IVIG) suppress overactive immune responses. This occurs through multiple mechanisms, including blockade of Fc receptors on immune cells, neutralization of autoantibodies, and modulation of cytokine production.

Administration and Dosage

Immunoglobulins are primarily administered in two ways:

Intravenous immunoglobulins (IVIG): Direct infusion into a vein, typically performed in a hospital or clinic setting, usually every 3 to 4 weeks.
Subcutaneous immunoglobulins (SCIG): Injection under the skin, often weekly or daily in smaller doses. This method is well suited for self-administration at home.

The exact dosage depends on body weight, the underlying condition, and the individual response to treatment, and is always determined by a qualified physician.

Side Effects

Immunoglobulin therapy is generally well tolerated but may cause side effects:

Headache, fever, and chills (often during infusion)
Nausea, vomiting, or abdominal discomfort
Fatigue and general malaise
Local reactions at the injection site (with subcutaneous administration)
In rare cases: allergic reactions, renal impairment, thromboembolic events, or aseptic meningitis

The risk of serious side effects is low and is further minimized by slow infusion rates and appropriate pre-medication.

Manufacturing and Safety

Immunoglobulin preparations are produced from the blood plasma of thousands of donors. The manufacturing process includes extensive purification and virus inactivation steps that reduce the risk of pathogen transmission to a minimum. All preparations are subject to strict quality controls in accordance with the guidelines of the European Medicines Agency (EMA).

References

European Medicines Agency (EMA): Guidelines on the clinical investigation of human normal immunoglobulin for intravenous administration (IVIG), EMA/CHMP/BPWP/94033/2010 rev. 2.
Orange JS et al. – Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. Journal of Allergy and Clinical Immunology, 2006.
Gelfand EW – Intravenous immune globulin in autoimmune and inflammatory diseases. New England Journal of Medicine, 2012; 367:2015-2025.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.